Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2 Pt 1
pubmed:dateCreated
1994-9-16
pubmed:abstractText
Cetirizine hydrochloride has proved effective in reducing allergic symptoms and can inhibit the infiltration of eosinophils in allergic late-phase responses in the skin. Because eosinophils are likely to play an important role in allergic late-phase reactions, we studied the effect of cetirizine on early and late asthmatic reactions and on levels of eosinophil cationic protein (ECP) in the blood after allergen challenge.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0091-6749
pubmed:author
pubmed:issnType
Print
pubmed:volume
94
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
231-9
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:8064075-Adolescent, pubmed-meshheading:8064075-Adult, pubmed-meshheading:8064075-Allergens, pubmed-meshheading:8064075-Animals, pubmed-meshheading:8064075-Antigens, Dermatophagoides, pubmed-meshheading:8064075-Asthma, pubmed-meshheading:8064075-Blood Proteins, pubmed-meshheading:8064075-Bronchial Provocation Tests, pubmed-meshheading:8064075-Cetirizine, pubmed-meshheading:8064075-Double-Blind Method, pubmed-meshheading:8064075-Eosinophil Granule Proteins, pubmed-meshheading:8064075-Eosinophils, pubmed-meshheading:8064075-Female, pubmed-meshheading:8064075-Forced Expiratory Volume, pubmed-meshheading:8064075-Glycoproteins, pubmed-meshheading:8064075-Humans, pubmed-meshheading:8064075-Lung, pubmed-meshheading:8064075-Male, pubmed-meshheading:8064075-Methacholine Chloride, pubmed-meshheading:8064075-Mites, pubmed-meshheading:8064075-Ribonucleases
pubmed:year
1994
pubmed:articleTitle
Lack of effect of cetirizine on early and late asthmatic response after allergen challenge.
pubmed:affiliation
Asthmacenter Heideheuvel, Hilversum, The Netherlands.
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't